Does Estimated Pulse Wave Velocity Add Prognostic Information? MORGAM Prospective Cohort Project

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Does Estimated Pulse Wave Velocity Add Prognostic Information? MORGAM Prospective Cohort Project. / Vishram-Nielsen, Julie K.K.; Laurent, Stephane; Nilsson, Peter M.; Linneberg, Allan; Sehested, Thomas S.G.; Greve, Sara V.; Pareek, Manan; Palmieri, Luigi; Giampaoli, Simona; Donfrancesco, Chiara; Kee, Frank; Mancia, Giuseppe; Cesana, Giancarlo; Veronesi, Giovanni; Kuulasmaa, Kari; Salomaa, Veikko; Kontto, Jukka; Palosaari, Tarja; Sans, Susana; Ferrieres, Jean; Dallongeville, Jean; Söderberg, Stefan; Moitry, Marie; Drygas, Wojciech; Tamosiunas, Abdonas; Peters, Annette; Brenner, Hermann; Njolstad, Inger; Olsen, Michael H.

In: Hypertension, Vol. 75, No. 6, 06.2020, p. 1420-1428.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Vishram-Nielsen, JKK, Laurent, S, Nilsson, PM, Linneberg, A, Sehested, TSG, Greve, SV, Pareek, M, Palmieri, L, Giampaoli, S, Donfrancesco, C, Kee, F, Mancia, G, Cesana, G, Veronesi, G, Kuulasmaa, K, Salomaa, V, Kontto, J, Palosaari, T, Sans, S, Ferrieres, J, Dallongeville, J, Söderberg, S, Moitry, M, Drygas, W, Tamosiunas, A, Peters, A, Brenner, H, Njolstad, I & Olsen, MH 2020, 'Does Estimated Pulse Wave Velocity Add Prognostic Information? MORGAM Prospective Cohort Project', Hypertension, vol. 75, no. 6, pp. 1420-1428. https://doi.org/10.1161/HYPERTENSIONAHA.119.14088

APA

Vishram-Nielsen, J. K. K., Laurent, S., Nilsson, P. M., Linneberg, A., Sehested, T. S. G., Greve, S. V., Pareek, M., Palmieri, L., Giampaoli, S., Donfrancesco, C., Kee, F., Mancia, G., Cesana, G., Veronesi, G., Kuulasmaa, K., Salomaa, V., Kontto, J., Palosaari, T., Sans, S., ... Olsen, M. H. (2020). Does Estimated Pulse Wave Velocity Add Prognostic Information? MORGAM Prospective Cohort Project. Hypertension, 75(6), 1420-1428. https://doi.org/10.1161/HYPERTENSIONAHA.119.14088

Vancouver

Vishram-Nielsen JKK, Laurent S, Nilsson PM, Linneberg A, Sehested TSG, Greve SV et al. Does Estimated Pulse Wave Velocity Add Prognostic Information? MORGAM Prospective Cohort Project. Hypertension. 2020 Jun;75(6):1420-1428. https://doi.org/10.1161/HYPERTENSIONAHA.119.14088

Author

Vishram-Nielsen, Julie K.K. ; Laurent, Stephane ; Nilsson, Peter M. ; Linneberg, Allan ; Sehested, Thomas S.G. ; Greve, Sara V. ; Pareek, Manan ; Palmieri, Luigi ; Giampaoli, Simona ; Donfrancesco, Chiara ; Kee, Frank ; Mancia, Giuseppe ; Cesana, Giancarlo ; Veronesi, Giovanni ; Kuulasmaa, Kari ; Salomaa, Veikko ; Kontto, Jukka ; Palosaari, Tarja ; Sans, Susana ; Ferrieres, Jean ; Dallongeville, Jean ; Söderberg, Stefan ; Moitry, Marie ; Drygas, Wojciech ; Tamosiunas, Abdonas ; Peters, Annette ; Brenner, Hermann ; Njolstad, Inger ; Olsen, Michael H. / Does Estimated Pulse Wave Velocity Add Prognostic Information? MORGAM Prospective Cohort Project. In: Hypertension. 2020 ; Vol. 75, No. 6. pp. 1420-1428.

Bibtex

@article{2772215f6d964c838277601844b7de9c,
title = "Does Estimated Pulse Wave Velocity Add Prognostic Information?: MORGAM Prospective Cohort Project",
abstract = "The Reference Values for Arterial Stiffness Collaboration has derived an equation using age and mean blood pressure to estimated pulse wave velocity (ePWV), which predicted cardiovascular events independently of Systematic COoronary Risk Evaluation (SCORE) and Framingham Risk Score. The study aim was to investigate the independent association between ePWV and clinical outcomes in 107 599 apparently healthy subjects (53% men) aged 19 to 97 years from the MORGAM Project who were included between 1982 and 2002 in 38 cohorts from 11 countries. Using multiple Cox-regression analyses, the predictive value of ePWV was calculated adjusting for country of inclusion and either SCORE, Framingham Risk Score, or traditional cardiovascular risk factors (age, sex, smoking, systolic blood pressure, body mass index [BMI], total and high-density lipoprotein cholesterol). Cardiovascular mortality consisted of fatal stroke, fatal myocardial infarction, or coronary death, and the composite cardiovascular end point consisted of stroke, myocardial infarction, or coronary death. Model discrimination was assessed using Harrell's C-statistic. Adjusting for country and logSCORE or Framingham Risk Score, ePWV was associated with all-cause mortality (hazard ratio, 1.23 [95% CI 1.20-1.25] per m/s or 1.32 [1.29-1.34]), cardiovascular mortality (1.26 [1.21-1.32] or 1.35 [1.31-1.40]), and composite cardiovascular end point (1.19 [1.16-1.22] or 1.23 [1.20-1.25]; all P<0.001). However, after adjusting for traditional cardiovascular risk factors, ePWV was only associated with all-cause mortality (1.15 [1.08-1.22], P<0.001) and not with cardiovascular mortality (0.97 [0.91-1.03]) nor composite cardiovascular end point (1.10 [0.97-1.26]). The areas under the last 3 receiver operator characteristic curves remained unchanged when adding ePWV. Elevated ePWV was associated with subsequent mortality and cardiovascular morbidity independently of systematic coronary risk evaluation and Framingham Risk Score but not independently of traditional cardiovascular risk factors.",
keywords = "cardiovascular risk, prognosis, pulse wave velocity, reclassification",
author = "Vishram-Nielsen, {Julie K.K.} and Stephane Laurent and Nilsson, {Peter M.} and Allan Linneberg and Sehested, {Thomas S.G.} and Greve, {Sara V.} and Manan Pareek and Luigi Palmieri and Simona Giampaoli and Chiara Donfrancesco and Frank Kee and Giuseppe Mancia and Giancarlo Cesana and Giovanni Veronesi and Kari Kuulasmaa and Veikko Salomaa and Jukka Kontto and Tarja Palosaari and Susana Sans and Jean Ferrieres and Jean Dallongeville and Stefan S{\"o}derberg and Marie Moitry and Wojciech Drygas and Abdonas Tamosiunas and Annette Peters and Hermann Brenner and Inger Njolstad and Olsen, {Michael H.}",
year = "2020",
month = jun,
doi = "10.1161/HYPERTENSIONAHA.119.14088",
language = "English",
volume = "75",
pages = "1420--1428",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams & Wilkins",
number = "6",

}

RIS

TY - JOUR

T1 - Does Estimated Pulse Wave Velocity Add Prognostic Information?

T2 - MORGAM Prospective Cohort Project

AU - Vishram-Nielsen, Julie K.K.

AU - Laurent, Stephane

AU - Nilsson, Peter M.

AU - Linneberg, Allan

AU - Sehested, Thomas S.G.

AU - Greve, Sara V.

AU - Pareek, Manan

AU - Palmieri, Luigi

AU - Giampaoli, Simona

AU - Donfrancesco, Chiara

AU - Kee, Frank

AU - Mancia, Giuseppe

AU - Cesana, Giancarlo

AU - Veronesi, Giovanni

AU - Kuulasmaa, Kari

AU - Salomaa, Veikko

AU - Kontto, Jukka

AU - Palosaari, Tarja

AU - Sans, Susana

AU - Ferrieres, Jean

AU - Dallongeville, Jean

AU - Söderberg, Stefan

AU - Moitry, Marie

AU - Drygas, Wojciech

AU - Tamosiunas, Abdonas

AU - Peters, Annette

AU - Brenner, Hermann

AU - Njolstad, Inger

AU - Olsen, Michael H.

PY - 2020/6

Y1 - 2020/6

N2 - The Reference Values for Arterial Stiffness Collaboration has derived an equation using age and mean blood pressure to estimated pulse wave velocity (ePWV), which predicted cardiovascular events independently of Systematic COoronary Risk Evaluation (SCORE) and Framingham Risk Score. The study aim was to investigate the independent association between ePWV and clinical outcomes in 107 599 apparently healthy subjects (53% men) aged 19 to 97 years from the MORGAM Project who were included between 1982 and 2002 in 38 cohorts from 11 countries. Using multiple Cox-regression analyses, the predictive value of ePWV was calculated adjusting for country of inclusion and either SCORE, Framingham Risk Score, or traditional cardiovascular risk factors (age, sex, smoking, systolic blood pressure, body mass index [BMI], total and high-density lipoprotein cholesterol). Cardiovascular mortality consisted of fatal stroke, fatal myocardial infarction, or coronary death, and the composite cardiovascular end point consisted of stroke, myocardial infarction, or coronary death. Model discrimination was assessed using Harrell's C-statistic. Adjusting for country and logSCORE or Framingham Risk Score, ePWV was associated with all-cause mortality (hazard ratio, 1.23 [95% CI 1.20-1.25] per m/s or 1.32 [1.29-1.34]), cardiovascular mortality (1.26 [1.21-1.32] or 1.35 [1.31-1.40]), and composite cardiovascular end point (1.19 [1.16-1.22] or 1.23 [1.20-1.25]; all P<0.001). However, after adjusting for traditional cardiovascular risk factors, ePWV was only associated with all-cause mortality (1.15 [1.08-1.22], P<0.001) and not with cardiovascular mortality (0.97 [0.91-1.03]) nor composite cardiovascular end point (1.10 [0.97-1.26]). The areas under the last 3 receiver operator characteristic curves remained unchanged when adding ePWV. Elevated ePWV was associated with subsequent mortality and cardiovascular morbidity independently of systematic coronary risk evaluation and Framingham Risk Score but not independently of traditional cardiovascular risk factors.

AB - The Reference Values for Arterial Stiffness Collaboration has derived an equation using age and mean blood pressure to estimated pulse wave velocity (ePWV), which predicted cardiovascular events independently of Systematic COoronary Risk Evaluation (SCORE) and Framingham Risk Score. The study aim was to investigate the independent association between ePWV and clinical outcomes in 107 599 apparently healthy subjects (53% men) aged 19 to 97 years from the MORGAM Project who were included between 1982 and 2002 in 38 cohorts from 11 countries. Using multiple Cox-regression analyses, the predictive value of ePWV was calculated adjusting for country of inclusion and either SCORE, Framingham Risk Score, or traditional cardiovascular risk factors (age, sex, smoking, systolic blood pressure, body mass index [BMI], total and high-density lipoprotein cholesterol). Cardiovascular mortality consisted of fatal stroke, fatal myocardial infarction, or coronary death, and the composite cardiovascular end point consisted of stroke, myocardial infarction, or coronary death. Model discrimination was assessed using Harrell's C-statistic. Adjusting for country and logSCORE or Framingham Risk Score, ePWV was associated with all-cause mortality (hazard ratio, 1.23 [95% CI 1.20-1.25] per m/s or 1.32 [1.29-1.34]), cardiovascular mortality (1.26 [1.21-1.32] or 1.35 [1.31-1.40]), and composite cardiovascular end point (1.19 [1.16-1.22] or 1.23 [1.20-1.25]; all P<0.001). However, after adjusting for traditional cardiovascular risk factors, ePWV was only associated with all-cause mortality (1.15 [1.08-1.22], P<0.001) and not with cardiovascular mortality (0.97 [0.91-1.03]) nor composite cardiovascular end point (1.10 [0.97-1.26]). The areas under the last 3 receiver operator characteristic curves remained unchanged when adding ePWV. Elevated ePWV was associated with subsequent mortality and cardiovascular morbidity independently of systematic coronary risk evaluation and Framingham Risk Score but not independently of traditional cardiovascular risk factors.

KW - cardiovascular risk

KW - prognosis

KW - pulse wave velocity

KW - reclassification

U2 - 10.1161/HYPERTENSIONAHA.119.14088

DO - 10.1161/HYPERTENSIONAHA.119.14088

M3 - Journal article

C2 - 32275189

AN - SCOPUS:85084693375

VL - 75

SP - 1420

EP - 1428

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 6

ER -

ID: 242408451